Upregulated expression of CXCL12 and its receptor CXCR4 was observed in various types of malignant CNS tumors, including low-grade oligodendrogliomas, oligoastrocytomas [199], and astrogliomas [200] as well as high-grade glioblastomas [201]. Here, CXCL12 is linked to glioblastoma.